Company / Accounts Receivable
OMEROS CORP Accounts Receivable History
FY2015-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$35.5M
FY2021
5-year range
$3.8M / $35.5M
FY2017-FY2021
Trend
+840.6%
vs FY2020
Sector context
#77 of 115
Health Care
What the data says
Accounts Receivable changed +841% YoY in FY2021, a notable deviation from the 6-year average annual change of +162%.
Based on SEC 10-K filings.
$35M in FY2021 with a 5-year CAGR of +24.3%.
Remained stable around $35M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +16.1%
- 5-Year CAGR
- +24.3%
- 10-Year CAGR
- -
Sector benchmark
#77 of 115 in Health CareTop 67% of 115This company $35.5M Sector average $1.1B
▼
-96.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.3%, indicating consistent growth.
- In FY2021, accounts receivable increased 840.6% year-over-year.
- Ranks #77 out of 115 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $35.5M | +840.6% |
| FY2020 | $3.8M | -89.2% |
| FY2019 | $35.1M | +54.8% |
| FY2018 | $22.7M | +32.6% |
| FY2017 | $17.1M | +43.1% |
| FY2016 | $11.9M | +92.3% |
| FY2015 | $6.2M | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026